{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:42:57Z","timestamp":1787503377956,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejps.2023.106577","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T02:06:09Z","timestamp":1693620369000},"page":"106577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Quantitative risk-benefit profiles of oral contraceptives, insulin sensitizers and antiandrogens for women with polycystic ovary syndrome: A model-based meta-analysis"],"prefix":"10.1016","volume":"190","author":[{"given":"Zhe","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue-hui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7999-7162","authenticated-orcid":false,"given":"Zheng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106577_bib0001","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/13625187.2018.1435779","article-title":"Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"23","author":"Amiri","year":"2018","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.ejps.2023.106577_bib0002","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.metabol.2017.05.001","article-title":"Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: a meta-analysis comparing products containing cyproterone acetate with third generation progestins","volume":"73","author":"Amiri","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.ejps.2023.106577_bib0003","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejps.2023.106577_bib0004","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejps.2023.106577_bib0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/000456328902600402","article-title":"Relative diagnostic value of serum non-SHBG-bound testosterone, free androgen index and free testosterone in the assessment of mild to moderate hirsutism","volume":"26","author":"Blight","year":"1989","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ejps.2023.106577_bib0006","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/psp4.12299","article-title":"Many flavors of model-based meta-analysis: part II - Modeling summary level longitudinal responses","volume":"7","author":"Boucher","year":"2018","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106577_bib0007","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1038\/psp.2013.26","article-title":"Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance","volume":"2","author":"Byon","year":"2013","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106577_bib0008","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0015-0282(16)57727-9","article-title":"Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism","volume":"64","author":"Ciotta","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejps.2023.106577_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European society of endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ejps.2023.106577_bib0010","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/humupd\/dmw016","article-title":"Hormonal contraceptives: pharmacology tailored to women's health","volume":"22","author":"De Leo","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ejps.2023.106577_bib0011","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12958-017-0313-y","article-title":"Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome","volume":"15","author":"de Medeiros","year":"2017","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.ejps.2023.106577_bib0012","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.fertnstert.2016.10.027","article-title":"Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits","volume":"106","author":"Dokras","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejps.2023.106577_bib0013","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.52.1.401","article-title":"Current concepts in the polycystic ovary syndrome","volume":"52","author":"Dunaif","year":"2001","journal-title":"Annu .Rev. Med."},{"key":"10.1016\/j.ejps.2023.106577_bib0014","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejps.2023.106577_bib0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ejps.2023.106577_bib0016","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-sponsored 3rd PCOS consensus workshop group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejps.2023.106577_bib0018","series-title":"Population pharmacokinetics guidance for industry","year":"2022"},{"key":"10.1016\/j.ejps.2023.106577_bib0017","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejps.2023.106577_bib0019","article-title":"Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome","volume":"8","author":"Fraison","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejps.2023.106577_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/14656566.2022.2108702","article-title":"Current and emerging drug treatment strategies for polycystic ovary syndrome","volume":"24","author":"Helvaci","year":"2023","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ejps.2023.106577_bib0033","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.ejps.2023.106577_bib0021","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/humupd\/dmx039","article-title":"Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Luque-Ram\u00edrez","year":"2018","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ejps.2023.106577_bib0022","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/clpt.2011.242","article-title":"Model-based meta-analysis for comparative efficacy and safety: application in drug development and beyond","volume":"90","author":"Mandema","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2023.106577_bib0023","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejps.2023.106577_bib0024","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/psp4.12091","article-title":"Model-based network meta-analysis: a framework for evidence synthesis of clinical trial data","volume":"5","author":"Mawdsley","year":"2016","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106577_bib0025","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, d-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejps.2023.106577_bib0026","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum. Reprod. Update"},{"issue":"4 Suppl","key":"10.1016\/j.ejps.2023.106577_bib0027","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.fertnstert.2008.09.070","article-title":"Long-term consequences of polycystic ovary syndrome on cardiovascular risk","volume":"91","author":"Rizzo","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejps.2023.106577_bib0028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejps.2023.106577_bib0029","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","article-title":"Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills","volume":"27","author":"Sitruk-Ware","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejps.2023.106577_bib0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/cen.14013","article-title":"Effect of the combined oral contraceptive pill and\/or metformin in the management of polycystic ovary syndrome: a systematic review with meta-analyses","volume":"91","author":"Teede","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ejps.2023.106577_bib0031","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejps.2023.106577_bib0032","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10928-013-9343-z","article-title":"Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics","volume":"41","author":"Thai","year":"2014","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2023.106577_bib0034","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/cpt.1462","article-title":"Model-based meta-analysis: optimizing research, development, and utilization of therapeutics using the totality of evidence","volume":"106","author":"Upreti","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2023.106577_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrb\u00edkov\u00e1","year":"2005","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ejps.2023.106577_bib0036","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.ejps.2023.106577_bib0037","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/ALN.0000000000003633","article-title":"Exposure-response relationship of tranexamic acid in cardiac surgery","volume":"134","author":"Zufferey","year":"2021","journal-title":"Anesthesiology"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:07:55Z","timestamp":1760530075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723002075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":37,"alternative-id":["S0928098723002075"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106577","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative risk-benefit profiles of oral contraceptives, insulin sensitizers and antiandrogens for women with polycystic ovary syndrome: A model-based meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106577"}}